Sona Nanotech Inc

OTCQB:SNANF USA Diagnostics & Research
Market Cap
$21.47 Million
Market Cap Rank
#25919 Global
#8811 in USA
Share Price
$0.19
Change (1 day)
-1.55%
52-Week Range
$0.19 - $0.23
All Time High
$11.38
About

Sona Nanotech Inc. operates as a nanotechnology life sciences company. It develops targeted hyperthermia and nanomedical therapies for the treatment of cancer. The company also develops gold nanoparticle products; lateral flow assay rapid tests; and bovine TB and concussion tests. Sona Nanotech Inc. is based in Halifax, Canada.

Sona Nanotech Inc - Asset Resilience Ratio

Latest as of April 2025: 0.17%

Sona Nanotech Inc (SNANF) has an Asset Resilience Ratio of 0.17% as of April 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$4.00K
Cash + Short-term Investments
Total Assets
$2.29 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2016–2024)

This chart shows how Sona Nanotech Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Sona Nanotech Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $4.00K 0.17%
Total Liquid Assets $4.00K 0.17%

Asset Resilience Insights

  • Limited Liquidity: Sona Nanotech Inc maintains only 0.17% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Sona Nanotech Inc Industry Peers by Asset Resilience Ratio

Compare Sona Nanotech Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
ADCNF
OTCGREY:ADCNF
Diagnostics & Research 1.12%
Berry Genomics Co Ltd
SHE:000710
Diagnostics & Research 0.45%
NSN Co. Ltd
KQ:031860
Diagnostics & Research 1.72%
JOONGANG DNM Co.Ltd
KQ:051980
Diagnostics & Research 27.26%
GeneMatrix Inc
KQ:109820
Diagnostics & Research 41.52%
Genoray Co. Ltd
KQ:122310
Diagnostics & Research 0.03%
Green Cross Lab Cell Corporation
KQ:144510
Diagnostics & Research 0.18%
Optipharm.CO.LTD
KQ:153710
Diagnostics & Research 20.73%

Annual Asset Resilience Ratio for Sona Nanotech Inc (2016–2024)

The table below shows the annual Asset Resilience Ratio data for Sona Nanotech Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-10-31 0.11% $4.00K $3.75 Million -0.11pp
2023-10-31 0.22% $6.00K $2.75 Million -0.64pp
2021-10-31 0.85% $13.00K $1.52 Million +0.68pp
2018-10-31 0.17% $5.50K $3.18 Million -20.32pp
2017-10-31 20.49% $355.58K $1.74 Million +8.92pp
2016-10-31 11.57% $561.35K $4.85 Million --
pp = percentage points